当前位置：
X-MOL 学术
›
Clin. Epigenet.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The epigenetic implication in coronavirus infection and therapy
Clinical Epigenetics ( IF 5.7 ) Pub Date : 2020-10-21 , DOI: 10.1186/s13148-020-00946-x Sandra Atlante 1 , Alessia Mongelli 1 , Veronica Barbi 1 , Fabio Martelli 2 , Antonella Farsetti 3 , Carlo Gaetano 1
Clinical Epigenetics ( IF 5.7 ) Pub Date : 2020-10-21 , DOI: 10.1186/s13148-020-00946-x Sandra Atlante 1 , Alessia Mongelli 1 , Veronica Barbi 1 , Fabio Martelli 2 , Antonella Farsetti 3 , Carlo Gaetano 1
Affiliation
Epigenetics is a relatively new field of science that studies the genetic and non-genetic aspects related to heritable phenotypic changes, frequently caused by environmental and metabolic factors. In the host, the epigenetic machinery can regulate gene expression through a series of reversible epigenetic modifications, such as histone methylation and acetylation, DNA/RNA methylation, chromatin remodeling, and non-coding RNAs. The coronavirus disease 19 (COVID-19) is a highly transmittable and pathogenic viral infection. The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which emerged in Wuhan, China, and spread worldwide, causes it. COVID-19 severity and consequences largely depend on patient age and health status. In this review, we will summarize and comparatively analyze how viruses regulate the host epigenome. Mainly, we will be focusing on highly pathogenic respiratory RNA virus infections such as coronaviruses. In this context, epigenetic alterations might play an essential role in the onset of coronavirus disease complications. Although many therapeutic approaches are under study, more research is urgently needed to identify effective vaccine or safer chemotherapeutic drugs, including epigenetic drugs, to cope with this viral outbreak and to develop pre- and post-exposure prophylaxis against COVID-19.
更新日期：2020-10-26
京公网安备 11010802027423号